4th Quarter - Report
BLANK ROME GOVERNMENT RELATIONS for ADVAMED
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to the medical device tax; H.R. 523, Protect Medical Innovation Act of 2013; H.R. 1295, Medical Device Tax Elimination Act; S. 232, Medical Device Access and Innovation Protection Act; S.J. RES.8; S.CON.RES.8
| Lobbyist | Covered position, as disclosed |
|---|---|
| J MICHAEL HOGAN | — |
| SHIMON STEIN | — |
Budget/Appropriations BUD
Issues relating to FDA funding Issues relating to implementation of MDUFA III (Public Law 112-144)
| Lobbyist | Covered position, as disclosed |
|---|---|
| J MICHAEL HOGAN | — |
| SHIMON STEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.